Status:
UNKNOWN
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
Lead Sponsor:
RenJi Hospital
Conditions:
Epithelial Ovarian Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
The purpose of this study is to identify the demographic and sociological characteristics of epithelial ovarian cancer in a cohort, identify the risk factors of epithelial ovarian cancer, effectively ...
Detailed Description
1. The clinical characteristics, preoperative hematological parameters of patients with epithelial ovarian cancer and patients with benign gynecological diseases, and the pathological stage, grade and...
Eligibility Criteria
Inclusion
- Patients were diagnosed as primary epithelial ovarian cancer with definite pathological stage and grade and underwent preoperative PET/CT examination, or patients diagnosed as benign gynecological diseases including ovarian cysts, uterine fibroids, and uterine prolapse.
- age between 18 to 80 years old;
- complete preoperative blood routine test results, blood biochemical indicators, and tumor markers;
Exclusion
- complicated with acute or chronic genital tract infectious diseases;
- patients with diagnosed tumors other than ovarian cancer;
- complicated with severe systemic diseases;
- pregnant or lactating women;
- patients diagnosed with recurrent epithelial ovarian cancer.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06085456
Start Date
September 1 2021
End Date
June 30 2024
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200127